PolyPid (PYPD) Current Leases (2022 - 2026)
PolyPid (PYPD) posted Current Leases of $1.2 million for Q1 2026, little changed sequentially from $1.2 million in Q4 2025, and up 28.07% YoY from $905000.0 in Q1 2025.
PolyPid (PYPD) Current Leases (2022 - 2026) Analysis & Trends
PolyPid has reported Current Leases for 5 years, with the latest figure at $1.2 million in Q1 2026.
- Quarterly Current Leases rose 28.07% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 28.07% YoY) and the FY2025 annual result came in at $1.2 million, up 26.33% from the prior year.
- Current Leases steadied at $1.2 million in Q1 2026 per PYPD's latest filing, from $1.2 million in the prior quarter.
- Over five years, Current Leases peaked at $1.2 million in Q4 2025 and troughed at $486000.0 in Q3 2023.
- A 5-year average of $882714.3 and a median of $896500.0 in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2024: Current Leases tumbled 43.69% in 2023, then jumped 82.72% in 2024.
- Over 5 years, Current Leases stood at $959000.0 in 2022, then sank by 43.69% to $540000.0 in 2023, then soared by 70.19% to $919000.0 in 2024, then grew by 26.33% to $1.2 million in 2025, then decreased by 0.17% to $1.2 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $1.2 million, $1.2 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | PolyPid | 113.30 Mn | 106.53 Mn | - | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.29 Mn |
| Mar 31, 2026 | 1.16 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 1.07 Mn |
| Mar 31, 2025 | 905,000.00 |
| Dec 31, 2024 | 919,000.00 |
| Sep 30, 2024 | 888,000.00 |
| Jun 30, 2024 | 873,000.00 |
| Mar 31, 2024 | 862,000.00 |
| Dec 31, 2023 | 540,000.00 |
| Sep 30, 2023 | 486,000.00 |
| Jun 30, 2023 | 638,000.00 |
| Mar 31, 2023 | 808,000.00 |
| Dec 31, 2022 | 959,000.00 |